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Abstract
Salmonella outer protein D (SopD) is a type III secreted virulence effector protein from Salmonella enterica. Full-length SopD and SopD
lacking 16 amino acids at the N-terminus (SopDDN) have been expressed as fusions with GST in Escherichia coli, purified with a typical
yield of 20–30 mg per litre of cell culture and crystallized. Biophysical characterization has been carried out mainly on SopDDN. Analytical
size exclusion chromatography shows that SopDDN is monomeric and probably globular in aqueous solution. The secondary structure
composition, calculated from the CD spectrum, is mixed (38% a-helix and 26% h-strand). Sequence analysis indicates that SopD contains a
coiled coil motif, as found in numerous other type III secretion system-associated proteins. This suggests that SopD has the potential for one
or more heterotypic protein–protein interactions. Limited trypsin digestion of SopDDN, monitored by both one-dimensional proton NMR
spectroscopy and SDS-PAGE, shows that the protein has a large, protease-resistant core domain of 286 amino acid residues. This single-
domain architecture suggests that SopD lacks a cognate chaperone. In crystallization trials, SopDDN produced better crystals than either full-
length SopD or trypsin-digested SopDDN. Diffraction to 3.0 A˚ resolution has so far been obtained from crystals of SopDDN.
D 2003 Elsevier B.V. All rights reserved.
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1. Introduction
Serovars of the Gram-negative intracellular pathogen
Salmonella enterica are a major economic and welfare
problem affecting both man and food-producing animals.
They cause a wide range of diseases from self-limiting
intestinal infections to severe systemic diseases, such as
typhoid fever [1,2]. Key to the bacterium’s pathogenesis are
two type III secretion systems (TTSSs) [3,4]. TTSSs resem-
ble molecular syringes for the injection of multiple bacterial
virulence effector proteins into the host cell cytoplasm that
modify host cell physiology to the benefit of the pathogen.
The supramolecular structure of the Salmonella TTSS
resembles the flagellar basal body and comprises two parts:
(i) a 7–8 nm wide, 60 nm long external needle; and (ii) a
shorter cylinder formed by plates (20–40 nm in diameter)
that presumably traverse both bacterial membranes and the
peptidoglycan layer [5,6]. Similar structures have also been
observed in Shigella flexneri [7,8]. Salmonella has two
TTSSs: on contact with the host cell, TTSS1 injects numer-
ous virulence effector proteins that subvert diverse signal
transduction pathways resulting in bacterial uptake and
enteritis, whereas TTSS2 is involved in survival of the
bacterial cell once inside the host cell.
One of the effector proteins secreted by Salmonella
TTSS1 is Salmonella outer protein D (SopD). SopD has been
shown to act in a concerted manner with another Salmonella
TTSS1 effector, SopB, to promote inflammatory responses
and fluid secretion in Salmonella dublin-infected calf intes-
tines [9]. Along with SipA, SopA, SopB and SopE2, SopD
has also been implicated in induction of diarrhea during
Salmonella typhimurium infection of calves [10]. The SopD
amino acid sequence is highly conserved among different
Salmonella serovars, particularly serovars dublin, typhi and
typhimurium (98% sequence identity across the complete
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SopD amino acid sequence). Incomplete sequences are avail-
able for SopD from several other Salmonella serovars. The
sequence identity between any of these incomplete sequences
and the three complete SopD sequences (serovars dublin,
typhi and typhimurium) is at least 69%.
No other sequence with obvious homology to the sopD
gene product sequence has been found among the GenBank-
EMBL entries, making it difficult to suggest a possible
function for SopD. Analysis of the genome sequence of S.
typhimurium [11] identified a homologue of SopD termed
SopD2, but even though SopD and SopD2 share 42%
sequence identity over their entire length, they seem to have
different intracellular sites of action: SopD2 was found to be
membrane-associated, whereas SopD localized to the cyto-
sol [12] (the precise targeting of SopD within the cytosol
remains unknown).
Knowledge of the function and three-dimensional struc-
ture of SopD would improve our understanding of the
molecular mechanisms involved in Salmonella infection.
Such understanding is necessary for the development of
new compounds to treat Salmonella-induced diseases. Here,
full-length and truncated versions of S. dublin SopD (Fig. 1)
have been expressed in anEscherichia coli expression system
and purified. Biophysical and sequence analyses have been
performed. Crystals have been produced for preliminary X-
ray analysis. In addition, since truncated SopD contains 12
methionine residues out of a total of 301 amino acid residues,
selenomethionine (SeMet) labelling of truncated SopD has
been carried out as this provides an attractive alternative to
heavy-atom phasing methods in solving crystal structures.
2. Materials and methods
2.1. SopD constructs
Due to its potential to increase solubility and facilitate
purification, we used a GST fusion system for expression of
both full-length SopD and SopD lacking 16 N-terminal
residues (SopDDN) (Fig. 1). Specifically, both full-length
and truncated sopD cDNA from S. dublin 2229 were cloned
into the pGEX-2T expression vector (Amersham Bioscien-
ces). The pGEX-2T vector expresses the protein of interest
as a fusion to the C-terminus of GST under the control of the
tac promoter, with a thrombin cleavage site between GST
and protein of interest.
2.2. Expression and purification of SopD and SopDDN
E. coli BL21 Stark (DE3) cells (Invitrogen) trans-
formed with pGEX-2T plasmids expressing either GST-
SopD or GST-SopDDN were grown in Luria–Bertani (LB)
medium with 100 Ag ml 1 ampicillin at 37 jC to an
optical density at 600 nm (OD600 nm) of 0.7–1.0 prior to
induction with 0.5 mM isopropyl-h-D-thiogalactoside
(IPTG) and incubation for a further 4 h at 30 jC. Bacterial
cells were harvested and resuspended in MTPBS lysis
buffer (150 mM NaCl, 16 mM Na2HPO4, 4 mM
NaH2PO4, 0.1% Tritonk X-100 and 0.2% h-mercaptoe-
thanol) and lysed by sonication. Cell debris was removed
by centrifugation (20,000 g, 20 min, 4 jC) to yield a
supernatant containing the soluble GST fusion protein. To
capture the fusion protein, the protein lysate was added to
glutathione sepharose 4B resin (Amersham Biosciences)
and incubated for 1 h at 4 jC on a roller mixer. The resin
was recovered by centrifugation (100 g, 5 min, 4 jC)
and washed with ice-cold thrombin cleavage buffer (50
mM Tris–HCl (pH 8.0), 150 mM NaCl, 2 mM dithio-
threitol (DTT), 5 mM MgCl2, 2.5 mM CaCl2).
SopD or SopDDN was separated from GST by thrombin
digestion: the washed and equilibrated resin was resuspended
in thrombin cleavage buffer and 15 U of thrombin (Calbio-
chem) was added. The resin/buffer slurry was then incubated
at 4 jC on a roller mixer for 12 h. Thrombin was removed by
incubation with p-aminobenzamidine agarose (Sigma). Fur-
ther purification was achieved by anion exchange (using an
A¨KTA Purifier system, Amersham Biosciences) on a Mono
QHR 5/5 column (AmershamBiosciences) equilibrated in 20
mM Tris–HCl, pH 8.0 (the SopD or SopDDN sample was
diluted two-fold using 20 mM Tris–HCl, pH 8.0 in order to
reduce the salt concentration prior to anion exchange).
Proteins were eluted with a 0–1 M NaCl gradient at a flow
rate of 1 ml min 1. Pure SopD or SopDDN fractions from
several anion exchange runs were pooled and concentrated to
10 mg ml 1 by ultrafiltration and exchanged into 10 mM
Tris–HCl (pH 7.5), 5 mM DTT. Between 20 and 30 mg of
pure SopD or SopDDN was obtained from 1 l of cell culture.
The identity of the purified proteins was confirmed using
mass spectrometry. SopD and SopDDN protein concentra-
tions were measured using the theoretically calculated ex-
tinction coefficient and by measuring A280.
2.3. Preparation of selenomethionine-labelled SopDDN
The expression protocol described above was slightly
altered to produce SeMet-labelled SopDDN. SeMet-la-
belled SopDDN was expressed and purified using the
GST fusion system described in Section 2.1. Because
the E. coli strain used is not a methionine autotroph,
Fig. 1. Schematic representation of the SopD constructs generated in this
study.
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SeMet labelling was performed by blocking the methio-
nine biosynthesis pathway with high concentrations of
exogenous amino acids known to inhibit methionine
biosynthesis, following a published protocol with minor
modifications [13]. E. coli strain BL21 (DE3) transformed
with the GST-SopDDN plasmid was grown overnight at
37 jC in LB medium containing 100 Ag ml 1 ampicillin.
The cells were harvested and resuspended in 1 l M9
minimal medium supplemented with 1 g l 1 NH4Cl, 40
ml 20% (w/v) glucose, 4 ml 0.1% (w/v) D-biotin, 4 ml
0.1% (w/v) thiamine–HCl, 1 ml 1 M MgSO4 and 0.3 ml
1 M CaCl2. The cells were grown at 37 jC until OD600 nm
reached 0.7–0.8 at which point 50 mg l 1 L-selenome-
thionine (Sigma), 100 mg l 1 L-lysine-hydrochloride
(Fisher), L-threonine and L-phenylalanine, and 50 mg l 1
L-leucine, L-isoleucine and L-valine (Melford) were added.
The cells were then incubated at 37 jC for 15 min before
induction with 0.1 mM IPTG and incubation at 25 jC for
a further 6 h. The cells were harvested and the SeMet-
SopDDN was purified using the same methods as for
SopDDN except that 10 mM DTT was added throughout
to prevent SeMet oxidation.
2.4. Limited proteolysis
A one-dimensional 1H NMR spectrum was recorded at 25
jC of 0.2 mM SopDDN in 10 mM perdeuterated Tris, 5 mM
perdeuterated DTT in D2O, pH 7.5. Proteolysis was then
performed by adding 1 Al of 10 mg ml 1 trypsin to this NMR
sample. Since there was no change in the NMR spectrum at
25 jC after adding trypsin, the sample temperature was
subsequently raised to 30 jC (again, there was no change
in the NMR spectrum) and then 37 jC. At intervals following
trypsin addition, a one-dimensional 1H NMR spectrum was
recorded and a sample taken for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) in order to
monitor changes in the protein due to trypsin cleavage. When
the reaction was complete, as assessed by one-dimensional
1H NMR, the trypsin-resistant core of SopDDN was sub-
jected to liquid chromatography-electrospray mass spec-
trometry to identify the site(s) of trypsin cleavage. Before
it was used for crystallization trials, the trypsin-digested
SopDDN NMR sample was purified by ion exchange as
described in Section 2.2 for SopD and SopDDN.
2.5. Circular dichroism
Circular dichroism (CD) was performed on a Jasco J-710
spectrometer using a 0.1 cm cell at 25 jC. Temperature was
controlled using a water-jacketed cell holder. The concen-
tration of the SopDDN sample was 2 mg ml 1 in 20 mM
Tris, pH 8.0 and 5 mM DTT. The system was purged with
22 l min 1 nitrogen during data acquisition. Spectra were
collected over a wavelength range of 185–260 nm at 0.1 nm
resolution and a band width of 2.0 nm. Final spectra were
the sum of 10 scans accumulated at a speed of 200 nm
min 1 with a response time of 0.5 s. Spectra were corrected
for contributions from buffer by subtracting the buffer
spectra. CD spectra were analysed using the K2D software
package [14].
2.6. Analytical size exclusion chromatography
Analytical size exclusion chromatography was carried
out at room temperature using an A¨KTA Purifier chroma-
tography system (Amersham Biosciences) on a Superdexk
75 HR 16/60 column (Amersham Biosciences) equilibrated
with 50 mM Tris–HCl (pH 7.5), 100 mM KCl (these are the
recommended conditions for the molecular weight stand-
ards). SopDDN was loaded at a concentration of 2 mg ml 1.
Protein was eluted over 1.5 column volumes at a flow rate
of 0.7 ml min 1. The column was calibrated with BSA (66
kDa), carbonic anhydrase (29 kDa), cytochrome c (12.5
kDa) and aprotinin (6 kDa).
2.7. Crystallization and data collection
SopD, SopDDN and trypsin-digested SopDDN (tSop-
DDN) crystals were grown using vapour diffusion techni-
ques. Initial crystallization trials were performed with sparse
matrix kits (Clear strategy I and II, Molecular Dimensions
Ltd.). The hanging drop was prepared by mixing 2 Al of 10
mg ml 1 SopD, SopDDN or tSopDDN with 2 Al of
reservoir solution and equilibrated against 1 ml reservoir
solution at 4 jC.
X-ray diffraction data from crystals mounted in a quartz
capillary tube were collected at room temperature with a
MAR Research image-plate detector using Cu Ka radia-
tion from a Rigaku rotating-anode generator. To achieve
acceptable statistics, all crystals were exposed for 30 min.
Diffraction data were processed using DENZO and SCA-
LEPACK [15].
2.8. Sequence analysis
Secondary structure predictions were conducted using
PHDsec [16]. Putative coiled coil domains were identified
using the COILS program [17]. A 28-residue window size
was used with weighting in favour of hydrophobic residues
at the a and d positions of the heptad repeat to avoid false
positives (MTIDK matrix). Further analysis was carried out
using the MULTICOIL program [18] to determine whether
the coiled coil domains were likely to assume dimeric or
trimeric structures.
3. Results and discussion
3.1. Expression and purification of SopD and SopDDN
Full-length SopD derived from S. dublin was cloned into
the expression plasmid pGEX-2T. Many of the type III
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effectors that have been crystallized have had some or all of
the N-terminal, non-catalytic portion removed [19–21].
This region is generally unstructured and as such may
hinder crystallization. With this in mind, we also generated
SopDDN, with a 16 amino acid N-terminal truncation (Fig.
1), and cloned this into pGEX-2T. These constructs express
SopD (approximately 36 kDa) or SopDDN (approximately
34 kDa) fused to the C-terminus of GST (26 kDa) with a
thrombin cleavage site between GST and SopD/SopDDN,
under the transcriptional control of the tac promoter. Induc-
tion of GST-SopD in E. coli BL21 Stark (DE3) at 30 jC
resulted in significant overexpression of a protein that
migrates as a 55 kDa band (based on its sequence, GST-
SopD is approximately 62 kDa) on Coomassie-stained SDS-
PAGE gels and which was absent from uninduced cells (Fig.
2, lanes 1 and 2). When the induced cells were harvested,
lysed, and centrifuged to separate soluble and insoluble
fractions, GST-SopD was detected mostly (approximately
65%) in the soluble fraction (Fig. 2, lanes 4 and 5).
GST-SopD was initially captured by affinity chroma-
tography using glutathione sepharose 4B resin (Fig. 2,
lane 8). SopD was then released from the GST moiety
by thrombin cleavage. GST-SopD thrombin cleavage
approached completion using an overnight incubation at
4 jC with no secondary degradation products visible by
SDS-PAGE, yielding protein with relatively little contam-
ination, as judged by SDS-PAGE (Fig. 2, lane 9). Since
protein with purity greater than 95% is required for
structural analyses, SopD was further purified using anion
exchange chromatography on a Mono Q column. Using a
linear 0–1 M NaCl gradient at pH 8.0, the protein eluted
at 0.2–0.3 M NaCl. The major elution fraction contained a
single 36 kDa band with the other major contaminants,
GST and thrombin, eluting off the column separately. Thus
ion exchange yielded SopD of greater than 95% homoge-
neity, as judged by SDS-PAGE analysis (Fig. 2, lane 11).
Between 20 and 30 mg of pure SopD was obtained from 1
l of cell culture.
SopDDN was expressed and purified as described above
for SopD. The yield of pure SopDDN was typically higher
than that of SopD, most likely due to the improved
solubility (approximately 75%) in E. coli of the GST-
SopDDN construct. This, together with the expectation that
SopDDN might crystallize more readily than SopD, meant
that most experiments were carried out on SopDDN rather
than SopD.
3.2. Expression and purification of selenomethionine-
labelled SopDDN
Both SopD constructs crystallized readily, but SopDDN
produced better quality crystals and was chosen to be
SeMet-labelled for structural determination. The expression
of SopDDN had to be slightly altered to produce SeMet-
labelled SopDDN. Induction at 30 jC with IPTG concen-
trations higher than 0.35 mM resulted in packaging of most
of the fusion protein into insoluble inclusion bodies. This is
most probably because the increased hydrophobicity of
surface-exposed SeMet residues compared to methionine
increases the aggregation tendency.
Cells cultured in M9 minimal medium typically have a
doubling time twice that of a richer medium such as LB, and
a longer induction time must be used to obtain sufficient
quantities of protein. When E. coli cells expressing SeMet-
SopDDN were induced for greater than 10 h, however, cell
death was observed and very little protein was expressed.
This may have been due to metabolism of SeMet into toxic
selenium compounds when the cells reached stationary
phase, leading to cell death. To circumvent these expression
problems, SopDDN was expressed at 25 jC with 0.1 mM
IPTG for 6 h. SeMet-SopDDN was purified using the same
protocol as for the native protein except for the addition of
10 mM DTT throughout the process to prevent SeMet
oxidation. About 10 mg of pure SeMet-SopDDN was
obtained from 1 l of cell culture.
3.3. SopDDN is a monomer in aqueous solution
Analysis by analytical size exclusion chromatography
showed that SopDDN forms a single species consistent with
a monomer of 34–35 kDa (data not shown), as calculated
from the line for a set of globular protein standards. This
compares with a mass of 34,246 Da predicted by the amino
acid sequence. Since analytical size exclusion chromatogra-
phy is sensitive to both molecular mass and shape of the
solute, the excellent match between predicted and experi-
mentally determined values suggests that SopDDN is a
monomeric, globular molecule.
Fig. 2. 15% SDS-PAGE of SopD expression and purification stained with
Coomassie brilliant blue. (1) Uninduced E. coli BL21 Stark (DE3) cells;
(2) induced E. coli BL21 Stark (DE3) cells expressing GST-SopD; (4 and
5) soluble and insoluble protein fractions after cell lysis; (6) supernatant
post-binding to glutathione sepharose 4B resin; (7) glutathione sepharose
4B resin wash; (8) GST-SopD bound to glutathione sepharose 4B resin; (9)
supernatant post-thrombin cleavage; (10) glutathione sepharose 4B resin
post-thrombin cleavage; (11) pure SopD after anion exchange chromato-
graphy; (M) molecular weight markers.
M.W. Wood et al. / Biochimica et Biophysica Acta 1698 (2004) 219–226222
3.4. SopD sequence analysis
Analysis of the protein sequence using the COILS server
http://www.ch.embnet.org/software/COILS_form.html)
highlighted the presence of a putative coiled coil motif
involving residues 271–298, suggesting that the protein
may self-associate or associate with one or more other
proteins. Further analysis using the MULTICOILS server
http://multicoil.lcs.mit.edu/cgi-bin/multicoil) produced a
very low probability ( < 0.1%) for dimer or trimer forma-
tion. This result, combined with the indication from size
exclusion chromatography (see above) that SopD is mo-
nomeric, means that any interactions mediated by the
coiled coil motif are likely to be heterotypic rather than
homotypic, although it should be emphasized that no
binding partners of SopD have yet been identified.
The coiled coil is a widespread and versatile motif
found in a variety of structural and regulatory proteins
[22]. Numerous other type III-secreted proteins possess
coiled coil motifs [23]. Coiled coil-containing proteins
associated with TTSSs can be placed into three broad,
function-based categories [23]: (i) proteins involved in
regulation of secretion; (ii) secreted translocators (pro-
teins involved in the formation of structures on the host
cell or bacterial cell membrane that are required for
passage through the host cell membrane of other effector
proteins and possibly translocators themselves); (iii) pro-
teins with enzyme activity. SopD is neither a regulator of
secretion nor is it a secreted translocator, and any
capacity of SopD to function as an enzyme remains to
be identified.
Fig. 4. Limited trypsin digestion of SopDDN. (A) Trypsin digestion time course monitored by 15% SDS-PAGE. (M) Molecular weight markers. Lanes 1–7: 0,
40, 60, 80, 100, 150, 180 min after raising the temperature of the NMR sample to 37 jC (note that there was no change in the NMR spectrum at 25 or 30 jC
after addition of trypsin). (B) Trypsin digestion time course monitored by 1H NMR spectroscopy. Upfield region of the 1H NMR spectrum of SopDDN (i) 0; (ii)
60; (iii) 100; (iv) 180 min after increasing the sample temperature to 37 jC.
Fig. 3. CD spectrum of SopDDN showing that the protein has mixed
secondary structure composition with a higher percentage of a-helix than
h-strand.
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3.5. SopD has a mixed secondary structure composition
The far-UV CD spectrum of SopD exhibits minima at
208 and 222 nm that are characteristic of a-helices (Fig. 3).
Calculation of secondary structure based on the CD spec-
trum using the K2D software package [14] indicates that
SopD comprises 38% a-helix and 26% h-strand. This is in
reasonable agreement with a theoretical prediction that
SopD is composed of 46% a-helix and 14% h-structure
[16]. Both experiment (CD spectroscopy) and theory (the
PredictProtein server at http://www.embl-heidelberg.de/pre-
dictprotein/predictprotein.html) therefore indicate that SopD
has a mixed secondary structure composition with a-helix in
greater abundance than h-strand.
3.6. Domain delineation by limited proteolysis
Delineation and sub-cloning of the protease-resistant
core domain of a protein often results in a polypeptide
that is more amenable to crystallization and/or NMR
studies. Limited trypsin proteolysis was consequently
carried out on an NMR sample of SopDDN (SopD was
not chosen for this experiment because an NMR sample
of SopD had previously exhibited extensive precipitation).
The time-course of proteolysis was monitored by both
SDS-PAGE (Fig. 4A) and 1H NMR spectroscopy (Fig.
4B). SDS-PAGE can report on size changes in a protein
due to proteolysis and the 1H NMR spectrum is very
sensitive to local changes in a protein due to proteolysis.
The end-point of the proteolysis reaction can be deter-
mined in real time by this method because there is no
further change in the NMR spectrum when the reaction is
complete.
There was no change in the NMR spectrum after trypsin
addition over a period of 2 h when the temperature was set
to 25 jC and then 30 jC, but on increasing the temperature
to 37 jC, slight changes were observed in the 1H NMR
spectrum (Fig. 4B). A 1H NMR spectrum was recorded and
a sample taken for SDS-PAGE at 40, 60, 80, 100, 150 and
180 min after raising the temperature of the sample to 37
jC. The SDS-PAGE band (Fig. 4A) and 1H NMR spectrum
(Fig. 4B) remained essentially constant between 60 and 180
min after raising the temperature to 37 jC. Since this
indicates that the SopD core domain produced by trypsin
digestion (tSopDDN, Fig. 1) is quite resistant to further
proteolysis, it was decided that, rather than sub-clone a new
construct corresponding to the protease-resistant core do-
main, trypsin digestion of SopDDN would be incorporated
into the original SopDDN purification protocol in order to
generate tSopDDN. This has been achieved with excellent
results (data not shown), although the poor initial crystalli-
zation trial results for tSopDDN (Section 3.7 below) meant
that tSopDDN has not been generated routinely.
The trypsin cleavage site was identified by liquid chro-
matography-electrospray mass spectrometry to be between
residues K14 and A15 of SopDDN, corresponding to K30
and A31 of full-length SopD (Fig. 1). These studies thus
revealed that a domain spanning residues 31–317 is stable
for at least 2 h in the presence of trypsin at 37 jC (Fig. 4).
This suggests that SopD comprises a single compact domain
with some of the putative N-terminal type III secretion
signal exposed. According to recent evidence for a universal
mode of interaction between TTSS chaperones and effectors
that involves independent chaperone binding and effector
domains [24], the single-domain architecture of SopD
suggests that this protein does not have a cognate bacterial
chaperone. The same authors, furthermore, proposed a
model for temporal control of secretion [24] according to
Fig. 5. Crystallization and X-ray diffraction of S. dublin SopDDN. (A)
Crystal of SopDDN grown at 19 jC using the hanging drop method. The
dimensions of the largest crystals were 0.1 0.1 0.2 mm. (B) Diffraction
pattern of SopDDN crystals. The resolution at the edge of the plate is 2.98 A˚.
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which SopD would be secreted in the second group of
effectors following effectors with cognate chaperones.
3.7. Crystallization and data collection
Initial crystallization screens using purified SopD and
SopDDN (10 mg ml 1) yielded needle-like crystals in a
variety of conditions with KBr and PEG as precipitants at
pH 6.5. These crystals grew within hours but were too small
to mount and their diffraction quality could not be assessed.
An initial crystallization screen using tSopDDN was not
successful, with several conditions resulting in protein
precipitation. SopDDN crystallized more readily under a
greater variety of conditions than SopD and was chosen to
optimise crystallization conditions. Attempts to increase the
crystal size by altering the temperature, protein concentra-
tion and precipitant had no discernible effect. Diffraction
quality crystals were obtained with the addition of phenol
(10–20 mM) and dioxane (5–10%) with 15% PEG 6K and
0.15 M KBr as precipitants buffered with 100 mM PIPES,
pH 6.5. Under these conditions, crystals grew to their
maximum size (0.1 0.1 0.2 mm; Fig. 5A) in 3 days
and diffracted X-rays to 3.0 A˚ on our ‘in-house’ X-ray
source (Fig. 5B). Crystals belonged to space group P21, with
unit-cell parameters a = 67.9 A˚, b = 81.8 A˚, c = 77.1 A˚,
a = 90.0j, b = 107.0j and c = 90.0j, and contained two
SopDDN molecules in the asymmetric unit with a solvent
content of 60%. Attempts at numerous flash-freezing pro-
tocols using PEG 400, glycerol, ethylene glycol and methyl
pentanediol as a cryoprotectant severely reduced the crys-
tals’ ability to diffract; higher quality data could only be
collected at room temperature with the crystal mounted in a
quartz capillary tube.
4. Conclusions
Since SopD does not exhibit significant sequence homol-
ogy to any other protein in the databank except SopD2 [12],
it has proven difficult to establish the precise biochemical
function(s) of SopD in Salmonella pathogenesis. Structural
information may assist in defining SopD function. To that
end, we have undertaken expression, purification, biophys-
ical characterization and initial crystallization studies on S.
dublin SopD and SopDDN. We have established that
SopDDN is monomeric in solution, of mixed secondary
structure composition, and that it comprises a short, prote-
ase-susceptible N-terminal region and a much larger prote-
ase-resistant core domain. The single-domain architecture
suggests that SopD is unlikely to have a cognate chaperone
[24]. High SopD sequence identity between different Salmo-
nella serovars means that these findings are likely to apply to
SopD proteins from most, if not all, Salmonella serovars.
Finally, we have made good progress in defining conditions
under which crystals of sufficient quality can be produced to
determine the three-dimensional structure of SopD.
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